Cite
Qian L, Xuemei L, Jitao L, et al. Dose-Dependent Efficacy of Aripiprazole in Treating Patients With Schizophrenia or Schizoaffective Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front Psychiatry. 2021;12:717715doi: 10.3389/fpsyt.2021.717715.
Qian, L., Xuemei, L., Jitao, L., Yun'Ai, S., & Tianmei, S. (2021). Dose-Dependent Efficacy of Aripiprazole in Treating Patients With Schizophrenia or Schizoaffective Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Frontiers in psychiatry, 12717715. https://doi.org/10.3389/fpsyt.2021.717715
Qian, Li, et al. "Dose-Dependent Efficacy of Aripiprazole in Treating Patients With Schizophrenia or Schizoaffective Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials." Frontiers in psychiatry vol. 12 (2021): 717715. doi: https://doi.org/10.3389/fpsyt.2021.717715
Qian L, Xuemei L, Jitao L, Yun'Ai S, Tianmei S. Dose-Dependent Efficacy of Aripiprazole in Treating Patients With Schizophrenia or Schizoaffective Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front Psychiatry. 2021 Aug 11;12:717715. doi: 10.3389/fpsyt.2021.717715. eCollection 2021. PMID: 34456770; PMCID: PMC8385236.
Copy
Download .nbib